A validated quantitative liquid chromatography–tandem quadrupole mass spectrometry method for monitoring isotopologues to evaluate global modified cytosine ratios in genomic DNA

•A highly sensitive method to estimate global modified cytosine ratio in DNA by LC–MS/MS.•Simultaneous analysis of the levels of trace analytes and abundant analytes by isotopologue-MRM.•The method is sufficiently sensitive to analyze 5hmC level even in small scale of cell cultures.•MLL-TET1 fusion...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2014-03, Vol.953-954, p.38-47
Hauptverfasser: Tsuji, Makoto, Matsunaga, Hironori, Jinno, Daisuke, Tsukamoto, Hiroki, Suzuki, Naoto, Tomioka, Yoshihisa
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•A highly sensitive method to estimate global modified cytosine ratio in DNA by LC–MS/MS.•Simultaneous analysis of the levels of trace analytes and abundant analytes by isotopologue-MRM.•The method is sufficiently sensitive to analyze 5hmC level even in small scale of cell cultures.•MLL-TET1 fusion protein may act as the dominant negative mutant form of TET1. 5-Hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC) represent important epigenetic modifications to DNA, and a sensitive analytical method is required to determine the levels of 5hmC in the genomic DNA of tumor cells or cultured cell lines because 5hmC is present at particular low levels in these cells. We have developed a sensitive liquid chromatography–tandem quadrupole mass spectrometric method for quantifying 5-hydroxymethyldeoxycytidine (5hmdC), 5-methyldeoxycytidine (5mdC), and deoxyguanosine (dG) levels using stable isotope labeled internal standards, and used this method to estimate the global level of 2 modified cytosines in genomic DNA prepared from small number of cells. The quantification limits for 5hmdC, 5mdC and dG were 20pM, 2nM and 10nM, respectively. MRM transitions for isotopologue (isotopologue-MRM) were used to quantify the 5mdC and dG levels because of the abundance of these nucleosides relative to 5hmdC. The use of isotopologue-MRM for the abundant nucleosides could also avoid the saturation of the detector, and allow for all three nucleosides to be analyzed simultaneously without the need for the dilution and re-injection of samples into the instrument. The global ratios of modified cytosine nucleosides to dG were estimated following the quantification of each nucleoside in the hydrolysate of genomic DNA. The limit of estimation for the global 5hmC level was less than 0.001% using 200ng of DNA. Using this method, we found that MLL-TET1, which a fusion protein in acute myelogenous leukemia, did not produce 5hmC, but interfered with TET1 activity to produce 5hmC in cells. Our analytical method is therefore a valuable tool for further studies aiming at a deeper understanding of the role of modified cytosine in the epigenetic regulation of cells.
ISSN:1570-0232
1873-376X
DOI:10.1016/j.jchromb.2014.01.050